Rhodiola Rosea
Market research indicates that Rhodiola Rosea will grow at a CAGR of 1.7 and reach a $37 million market value between 2021 and 2026.
Research over the last few decades has supported claims that adaptogens found in this plant have been linked to improving symptoms of chronic stress and burnout as well as supporting brain health.
In a five-year period ending in November 2020, search engine popularity for the term "Rhodiola Rosea" has just about doubled.
